Ngwa ngwa nyocha Typhoid ọkachamara n'iji ahụike, kaseti nyocha ngwa ngwa otu nzọụkwụ
Mmetụta ụlọ ọgwụ, Nkọwapụta na izi ezi
A nwalewo ule ngwa ngwa nke influenza A+B ma e jiri ya tụnyere RT-PCR.539 nasopharyngeal swabs na oropharyngeal swabs ka ejiri nyocha Influenza A+B ngwa ngwa.
| Ihe | Ntinye uche | Ihe | Ntinye uche |
| Mgbasa imi | 15% v/v | Hemoglobin | 10% v/v |
| Mucin | 0.5% w/v | Mupirocin | 10 mg/mL |
| Ọnụ mmiri imi | 15% v/v | Ịsacha ọnụ | / |
| Chloraseptic | 1.5 mg / ml | Levofloxacin | 40 ug/mL |
| Oseltamivir | 2ug/mL | Ribavirin | 0.2ug/mL |
| Fluticasone propionate | 5% v/v | Ceftriaxone | 800 ug/mL |
| Tobramycin | 4ug/mL | Saline imi na-efesa | 10% v/v |
Maka influenza A
| Usoro | RT-PCR | Mgbakọta rịzọlt | ||
| Nnwale nke influenza A+B ngwa ngwa | Nsonaazụ | Nke dị mma | Ihe ọjọọ | |
| Nke dị mma | 116 | 1 | 117 | |
| Ihe ọjọọ | 5 | 417 | 422 | |
| Mgbakọta rịzọlt | 121 | 418 | 539 | |
Mmetụta ụlọ ọgwụ: 95.87% (95% CI: 90.69% ~ 98.22%)
Nkọwa ụlọ ọgwụ: 99.76% (95% CI: 98.66% ~ 99.96%)
Mkpokọta ọnụego ndakọrịta: 98.89% (95% CI: 97.59% ~ 99.49%).
Maka influenza B:
| Usoro | RT-PCR | Mgbakọta rịzọlt | ||
| Nnwale nke influenza A+B ngwa ngwa | Nsonaazụ | Nke dị mma | Ihe ọjọọ | |
| Nke dị mma | 97 | 1 | 98 | |
| Ihe ọjọọ | 6 | 435 | 441 | |
| Mgbakọta rịzọlt | 103 | 436 | 539 | |
Mmetụta ụlọ ọgwụ: 94.17% (95% CI: 87.87% ~ 97.30%)
Nkọwa ụlọ ọgwụ: 99.77% (95% CI: 98.71% ~ 99.96%)
Mkpokọta ọnụego ndakọrịta: 98.70% (95% CI: 97.34% ~ 99.37%).
Mmetụta nyocha/LOD
 | Ụgwọ nke ụlọ ọrụ Hangzhou Aichek Medical Technology Co., Ltd. Jinxing Cun, Obodo Yuhang, Yuhang Mpaghara (Sci-Tech City n'ọdịnihu), Hangzhou, Zhejiang, PR China |
 | SUNGO Europe BV Olympisch Stadion 24, 1076DE Amsterdam, Netherlands |
Achọpụtara oke nchọpụta (LOD) site n'ịtụle ọkwa dị iche iche nke nje influenza A na nje influenza B na Influenza A+B Antigen Rapid Test.Edepụtara nleba anya dị ka ọkwa LOD nwalere n'okpuru.
Influenza A (H3N2): 5×103 TCID50/mL
Influenza A (H1N1): 2.5×103 TCID50/mL
Influenza A (H1N1 pdm09): 2.5×103 TCID50/ml
Influenza B (Yamagata): 3.5×103 TCID50/mL
Influenza B (Victoria): 1.0×103 TCID50/mL
Nkọwapụta nkọwa (Cross Reactivity)
Iji chọpụta nkọwa nyocha nke Influenza A+B Antigen Rapid Test, a nwalere ọtụtụ commensal ma ọ bụ pathogenic microorganisms nke nwere ike ịdị na traktị iku ume elu.
A na-enyocha ụdị dị mma na nke na-adịghị mma na ụmụ nje ndị a na ntinye nke 106 TCID50/mL, gụnyere SARS-CoV-2, coronavirus Human HKU1, OC43, NL63, 229E, MERS, Rhinovirus, Adenovirus, Enterovirus, Metapneumozavirus, Parainfluen. nje syncytial, Mycoplasma oyi baa, Chlamydia ka oyi baa, Streptococcus ka oyi baa, Staphylococcus aureus, Mycobacterium ụkwara nta, Haemophilus influenzae, Streptococcus pyogenes.Ọnweghị mmeghari mmegharị ahụ ahụrụ site na Influenza A+B Antigen Rapid Test.
Ezubere iji
Influenza A+B Antigen Rapid Test bụ mpụta eruba immunoassay ezubere maka qualitative nchọpụta influenza A na influenza B antigens na nasopharyngeal swab na oropharyngeal swab.
Uru ụlọ ọrụ
1.Professional Manufacturer, a mba-larịị technologically elu "ibu" Enterprise
2.Na-ebuga ngwongwo dị ka ịrịọ arịrịọ
3.ISO13485, CE, Kwadebe akwụkwọ mbupu dị iche iche
4.zaghachi ndị ahịa ajụjụ n'ime awa 24
